Characterizes immune alterations in progressive multiple sclerosis, indicating distinct cellular signatures.
To characterize cerebrospinal fluid (CSF) immune alterations associated with progressive multiple sclerosis (PMS) and identify cellular signatures distinguishing progressive from relapsing disease stages.
No takes yet. Share an insight, caveat, or question.
Bernard‐Valnet et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: